The active investors in this premium marketing data are enticed by stocks inmedical device & diagnostic equipmentcompaniesas well as pharmaceutical companies.  These investors are attracted to the high yield opportunities available in companies with new or emerging medical advancements and breakthroughs.  Many of these stocks are offered as IPOs, Bulletin Boards, or are on the NASDAQ Small Cap markets.  The qualified inquiries or investments made within the last 12 months by the individuals in this premium mailing list with optional opt-in email addresses have been made for a minimum of $10,000.  All marketing data points, self reported and public, are audited and double verified each month through 2 or more organic sources ensuring superior accuracy and a receptive and responsive audience.